Optimal duration of therapy in the first line treatment of metastatic colorectal cancer: Single center experience

Optimal duration of therapy in the first line treatment of metastatic colorectal cancer: Single center experience

Background/Aim. Standard treatment options for the first-line treatment of metastatic colorectal carcinoma (mCRC) are 5-fluorouracil, folinic acid, oxaliplatin (FOL-FOX4)/capecitabine (CapOx), plus bevacizumab (bev) and 5-fluorouracil, folinic acid and irinotecan (FOLFIRI) plus bev. The aim of this...

Full description

Saved in:
Bibliographic Details
Main Authors: Jungić Saša, Tubić Biljana, Berendika Jelena, Gojković Zdenka, Rakita Ivanka, Vještica Milka, Đokanović Dejan, Gajanin Radoslav
Format: Article
Language:English
Published: Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2022-01-01
Series:Vojnosanitetski Pregled
Subjects:
clinical protocols
colorectal neoplasms
drug-related side effects and adverse reactions
duration of therapy
folfox protocol
ifl protocol
neoplasm metastasis
survival
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2022/0042-84502100053J.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items